KB
Kimelman & Baird Portfolio holdings
AUM
$1.23B
This Quarter Return
+5.3%
1 Year Return
+13.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$569M
AUM Growth
+$569M
(+4%)
Cap. Flow
-$391K
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
43.97%
Holding
109
New
6
Increased
21
Reduced
35
Closed
3
Top Buys
| 1 |
Fabrinet
FN
|
$6.6M |
| 2 |
Digimarc
DMRC
|
$2.26M |
| 3 |
Minerals Technologies
MTX
|
$1.04M |
| 4 |
Quaker Houghton
KWR
|
$265K |
| 5 |
Enterprise Products Partners
EPD
|
$221K |
Top Sells
| 1 |
STR
QUESTAR CORP
STR
|
$8.6M |
| 2 |
Copart
CPRT
|
$1.2M |
| 3 |
Amazon
AMZN
|
$305K |
| 4 |
Mondelez International
MDLZ
|
$207K |
| 5 |
CMD
Cantel Medical Corporation
CMD
|
$206K |
Sector Composition
| 1 | Industrials | 21.32% |
| 2 | Healthcare | 17.04% |
| 3 | Communication Services | 10.96% |
| 4 | Financials | 10.77% |
| 5 | Consumer Discretionary | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Emerson Electric
EMR
$72.9B
| $8.39M | 1.47% |
153,835
| – | – |
|
27
Wells Fargo
WFC
$258B
| $7.57M | 1.33% |
170,938
+144
| +0.1% | +$6.38K |
|
28
Dover
DOV
$24B
| $7.42M | 1.31% |
100,800
| – | – |
|
29
Chevron
CVX
$318B
| $7.4M | 1.3% |
71,861
-160
| -0.2% | -$16.5K |
|
30
Novartis
NVS
$248B
| $6.97M | 1.23% |
88,262
+250
| +0.3% | +$19.7K |
|
|
31
Fabrinet
FN
$12.1B
| $6.6M | 1.16% |
+147,950
| New | +$6.6M |
|
32
Camden National
CAC
$683M
| $6.59M | 1.16% |
138,043
| – | – |
|
|
RDS.A
33
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.54M | 0.97% |
110,665
-300
| -0.3% | -$15K |
|
34
Norfolk Southern
NSC
$62.4B
| $5.46M | 0.96% |
56,300
| – | – |
|
35
Alphabet (Google) Class C
GOOG
$2.79T
| $5.34M | 0.94% |
6,865
-5
| -0.1% | -$3.89K |
|
36
McDonald's
MCD
$226B
| $4.86M | 0.85% |
42,150
-300
| -0.7% | -$34.6K |
|
37
Occidental Petroleum
OXY
$45.6B
| $4.79M | 0.84% |
65,621
+1,903
| +3% | +$139K |
|
38
Honeywell
HON
$136B
| $4.19M | 0.74% |
35,932
| – | – |
|
39
DuPont de Nemours
DD
$31.6B
| $4.09M | 0.72% |
78,847
| – | – |
|
40
PepsiCo
PEP
$203B
| $3.81M | 0.67% |
34,990
-100
| -0.3% | -$10.9K |
|
41
Bristol-Myers Squibb
BMY
$96.7B
| $3.49M | 0.61% |
64,778
+1
| +0% | +$54 |
|
42
M&T Bank
MTB
$31B
| $3.49M | 0.61% |
30,034
| – | – |
|
43
AT&T
T
$208B
| $2.8M | 0.49% |
68,885
+5
| +0% | +$215 |
|
44
Procter & Gamble
PG
$370B
| $2.67M | 0.47% |
29,800
| – | – |
|
45
NextEra Energy, Inc.
NEE
$148B
| $2.56M | 0.45% |
20,921
-19
| -0.1% | -$2.32K |
|
46
Nucor
NUE
$33.3B
| $2.27M | 0.4% |
45,900
-10
| -0% | -$495 |
|
47
Kimberly-Clark
KMB
$42.5B
| $2.11M | 0.37% |
16,690
| – | – |
|
48
Johnson & Johnson
JNJ
$429B
| $1.99M | 0.35% |
16,867
-500
| -3% | -$59.1K |
|
49
AbbVie
ABBV
$374B
| $1.8M | 0.32% |
28,500
| – | – |
|
50
3M
MMM
$81B
| $1.74M | 0.31% |
9,868
| – | – |
|